The Recombinant Staphylococcus haemolyticus UPF0754 membrane protein SH1116 (SH1116) is a protein derived from the bacterium Staphylococcus haemolyticus, which is a common skin commensal but has emerged as a significant nosocomial pathogen. This protein is expressed in Escherichia coli and is fused with an N-terminal His tag for easier purification and identification. The SH1116 protein is of particular interest due to its potential role in bacterial membrane functions and its implications in understanding bacterial pathogenicity.
Protein Length: The recombinant SH1116 protein is a full-length protein consisting of 378 amino acids.
Expression System: It is expressed in E. coli, which is a common host for recombinant protein production due to its well-understood genetics and efficient expression systems.
Tag: The protein is tagged with a His tag at the N-terminal, facilitating purification using nickel affinity chromatography.
Form: The protein is provided in a lyophilized powder form for convenience in storage and transportation.
Purity: The purity of the protein is greater than 90%, as determined by SDS-PAGE, indicating a high level of purification.
| Characteristics | Description |
|---|---|
| Protein Length | Full Length (1-378 amino acids) |
| Expression System | Escherichia coli |
| Tag | N-terminal His tag |
| Form | Lyophilized powder |
| Purity | >90% (SDS-PAGE) |
The amino acid sequence of SH1116 is crucial for understanding its structure and potential functions. The sequence starts with MQAFLVILFMVVVGAVIGGVTNVIAIRMLFHPFKPYYIFKMRIPFTPGLIPKRREEIATKIGQVIEEHLITESVILQKLNEPNTREAINDLVIKQLSKLKSDDATIRKFANQFDFDLDLD DLINNKLDKTIINKLNNYYYDKQATSINEILPADVITMVDEKLDQAGDLIRERARNYLSSDKGARDIYDMLDTFFAEKGKIVGLLQMFMTKESIAERVQHELIRLTRHPKAKVIIDKVIRDEYETLKSQPLSHVVKEEQFTNISESLVHLVITNLQLNEKMDTPISKLTPKLVDQIQVGVANTITDLIIKQASNHLSTIMTKINLRQMVENQINTFDLDYIERLIIEIANKELKLIMSLGFILGGIIGFFQGIVAIFV.
KEGG: sha:SH1116
STRING: 279808.SH1116
For recombinant expression of SH1116, E. coli-based systems have proven effective, as documented in the production of His-tagged SH1116 . When designing expression systems for membrane proteins like SH1116, several methodological considerations are crucial:
Vector selection: Vectors with tightly controlled promoters (such as T7) allow for regulated expression
Host strain optimization: BL21(DE3) or C41/C43 strains specifically engineered for membrane protein expression are recommended
Induction conditions: Lower temperatures (16-25°C) and reduced inducer concentrations often improve proper folding
Media supplementation: Addition of glycerol (0.5-1%) can enhance membrane protein stability
The choice between prokaryotic and eukaryotic expression systems depends on research goals, with E. coli offering simplicity and high yields but potentially lacking post-translational modifications that might be relevant for functional studies .
Purification of SH1116 requires specialized approaches due to its membrane protein nature:
Solubilization: Carefully selected detergents (DDM, LDAO, or Triton X-100) at concentrations just above their critical micelle concentration (CMC)
Affinity chromatography: Immobilized metal affinity chromatography (IMAC) using the His-tag for initial capture
Buffer composition: Inclusion of stabilizing agents such as glycerol (6%) in Tris/PBS-based buffers (pH 8.0)
Storage: Lyophilization or storage in solution with 50% glycerol at -20°C/-80°C, avoiding repeated freeze-thaw cycles
For reconstitution, it is recommended to briefly centrifuge the vial before opening and reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol for long-term storage stability .
Determining the exact topology of membrane proteins like SH1116 requires multiple complementary techniques:
Computational prediction: Tools like TMHMM, Phobius, or TOPCONS can predict transmembrane regions based on the amino acid sequence
Protease accessibility assays: Limited proteolysis followed by mass spectrometry to identify exposed regions
Cysteine scanning mutagenesis: Systematic replacement of residues with cysteine followed by accessibility studies
Fluorescence microscopy: GFP-fusion constructs at various positions to determine cytoplasmic vs. periplasmic localization
Cryo-EM or X-ray crystallography: For high-resolution structural determination if the protein can be stabilized
By combining these approaches, researchers can develop a comprehensive model of how SH1116 is oriented within the membrane, which is crucial for understanding its potential interactions with other cellular components .
Membrane proteins like SH1116 present unique challenges for interaction studies. A multi-method approach is recommended:
Co-immunoprecipitation with crosslinking: Chemical crosslinkers can trap transient interactions before solubilization
Bacterial two-hybrid systems: Modified for membrane protein analysis
Surface plasmon resonance (SPR): For quantitative binding kinetics using purified components
Proximity labeling approaches: BioID or APEX2 fusions to identify neighboring proteins in the native environment
Recent research on membrane protein assembly has identified complexes like the PAT (protein associated with the translocon) that assist in proper assembly of multi-spanning membrane proteins . Using chemical crosslinkers to trap factors involved in assembly has proven valuable in identifying previously uncharacterized interaction partners, which may also be applicable to studying SH1116 interactions .
While specific functions of SH1116 itself are still being elucidated, research on S. haemolyticus provides context for understanding potential roles of membrane proteins in virulence:
Clinical S. haemolyticus isolates show distinct genetic signatures compared to commensal strains, including differences in membrane-associated proteins
Hospital-adapted strains typically possess genes related to biofilm formation and antibiotic resistance
The comparison between clinical and commensal S. haemolyticus isolates reveals:
| Characteristic | Clinical Isolates | Commensal Isolates | Significance |
|---|---|---|---|
| Multi-drug resistance | 88% (108/123) | 11% (5/46) | p < 0.05 |
| Specific genomic markers | SraP homolog commonly present | SraP homolog less common | Potential virulence factor |
| Biofilm formation | Higher prevalence | Lower prevalence | Persistence in hospital environments |
| Mobile genetic elements | Enriched | Less common | Horizontal gene transfer |
As a membrane protein, SH1116 may participate in adaptation to hospital environments, potentially contributing to surface properties that affect colonization or biofilm formation .
Comparative genomic analysis between clinical and commensal S. haemolyticus isolates reveals distinct phylogenetic clustering . While specific variations in SH1116 are not detailed in the search results, broader patterns in membrane proteins show:
Clinical isolates often contain distinct conserved differences in surface-associated genes compared to commensal isolates
Horizontal gene transfer appears to be a major driver in the evolution of clinical isolates
Genetic rearrangements and beneficial point mutations in surface-associated genes are more common in hospital-adapted strains
For comprehensive analysis of SH1116 variations across strains, researchers should consider:
Whole genome sequencing of diverse isolates
Selection pressure analysis using dN/dS ratios
Structural modeling to predict functional impacts of observed variations
Experimental validation through site-directed mutagenesis
Membrane proteins like SH1116 present significant structural biology challenges:
Detergent selection: Screening multiple detergents or nanodiscs/amphipols for optimal stability
Crystallization barriers: Use of antibody fragments or fusion partners to increase polar surface area
Conformational heterogeneity: Ligand or inhibitor binding to stabilize a single conformation
Alternative approaches: Cryo-EM or solid-state NMR when crystallization proves difficult
Researchers should consider implementing the lipidic cubic phase (LCP) method, which has proven successful for many membrane proteins. For intrinsically disordered regions, hydrogen/deuterium exchange mass spectrometry (HDX-MS) can provide valuable conformational information even without a crystal structure.
As S. haemolyticus emerges as a reservoir of antibiotic resistance , membrane proteins like SH1116 represent potential novel therapeutic targets. Strategic approaches include:
High-throughput screening: Developing assays to identify small molecule binders
Structure-based drug design: Once structural information is available
Immunotherapeutic approaches: Evaluating accessibility of epitopes for antibody targeting
Resistance mechanism analysis: Determining if SH1116 contributes directly or indirectly to resistance phenotypes
The increasing clinical relevance of S. haemolyticus as a nosocomial pathogen with multi-drug resistance emphasizes the importance of novel target exploration. Membrane proteins often serve essential functions that can be exploited for antimicrobial development.
Advanced imaging and biophysical techniques can elucidate SH1116's role in membrane organization:
Super-resolution microscopy: Techniques like PALM/STORM to visualize protein clustering in bacterial membranes
FRET analysis: To detect protein-protein interactions within the membrane
Native mass spectrometry: For analyzing intact membrane protein complexes
Neutron reflectometry: To determine protein orientation and insertion depth
Understanding membrane organization is critical as proper assembly of membrane proteins is essential for bacterial survival. Recent discoveries of chaperones that assist membrane protein assembly, such as the PAT complex, highlight the complex machinery involved in ensuring correct topology and folding .